Developer docs
API playgroundTry for free, no card

Search company profiles

Noro-Moseley Partners

Full company profile

uuid0000972

Namestring
Noro-Moseley Partners
Legal namestring
Noro-Moseley Partners
Websiteurl
noromoseley.com
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Noro-Moseley Partners (NMP) is an Atlanta-based early growth equity firm founded in 1983 that invests in B2B technology and healthcare companies across the United States (excluding the West Coast). The firm targets high-growth businesses with 50%+ year-over-year revenue growth, $2-20M revenue run rates, compelling unit economics, significant market disruption potential, and minimal prior funding (under $20M), deploying $5-20M per company. NMP's two sector pillars are software/SaaS/internet security/tech-enabled services (led by General Partner Alan Taetle) and healthcare IT and healthcare services (led by Managing General Partner Allen Moseley). The firm operates as a private limited partnership and has invested approximately $800M across 200+ companies since inception, with exits representing over $5B in aggregate enterprise value since 2015 and 13 exits since 2013 totaling $3.3B.

NMP earns revenue through a standard private equity structure: management fees (typically ~2%) on committed and invested capital across its fund vintages, and carried interest (typically ~20%) on profits from successful portfolio company exits. The firm closed its eighth fund (NMP VIII) in May 2019 at a hard cap of $180M, $30M oversubscribed against its $150M target. The LP base includes public and sovereign pension plans, health plans and health systems, foundations, endowments, and family offices, providing both capital and, in the healthcare segment, potential strategic partnership channels for portfolio companies. The investing team of approximately 10 professionals is led by four General Partners (Moseley, Taetle, Kamath, McClelland), supported by a Principal, Senior Associate, Vice President, and Executive-in-Residence.

Notable exits include Virtustream (acquired by Dell EMC for $1.2B in 2015), Wellcentive (acquired by Philips), Clearleap (IBM), FSLogix (Microsoft), Red Canary (Zscaler, 2025), TrendKite (Cision), Navitas Credit Corp, Contessa (Amedisys, 2021), SupplyPike (SPS Commerce, 2024), and Findhelp (TPG, 2026). The firm distributes its investment offering through direct relationships with founders and management teams, referrals from its portfolio ecosystem, and regional engagement via venture competitions such as Venture Atlanta. As a partnership, NMP is owned by its partners and is not publicly traded or affiliated with a parent entity.

Short descriptiontext

Noro-Moseley Partners is an Atlanta-based early growth equity firm founded in 1983 that invests $5-20M in B2B technology and healthcare companies with $2-20M in revenue and 50%+ growth, primarily across the Southeast and national US markets excluding the West Coast.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAtlanta, United States
HQ citystring
Atlanta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, growth equity investing, private equity, B2B technology investing, healthcare venture capital
Industry1 code
PRIMARYFSANACAO
Multi-Sector / Generalist Growth Equity
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital and Growth Equity
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeManaged Services
Description

NMP charges management fees on their assets under management as a standard private equity practice. Fund VIII closed at $180 million with typical 2% management fee structure.

noromoseley.com
2Carried Interest
TypeLicensing Royalties
Description

The firm earns carried interest (typically 20%) on profits from successful portfolio company exits. Their exits represent over $5 billion in aggregate enterprise value since 2015, generating substantial carried interest.

noromoseley.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Noro-Moseley Partners is a venture capital and early-growth equity firm that invests institutional fund capital into privately held B2B technology and healthcare companies, typically leading or co-leading expansion-stage rounds. The firm raises capital from limited partners into closed-end funds, deploys that capital into portfolio companies in exchange for equity, and provides board-level support, strategic guidance, and follow-on financing to founders and management teams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over $5 billion in aggregate enterprise value generated from exits since 2015
+3 more records
Product overview1 text field

Noro-Moseley Partners is an early growth equity investment firm, not a technology product company. The firm provides investment capital and partnership services to B2B technology and healthcare companies. As such, it does not offer a unified product platform or individual software products/modules. Its investment offering consists of capital deployment ($5-20M investments), strategic advisory, and board-level support for portfolio companies.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Frontier Capital
TypeDirect peer
Description

Charlotte-based growth equity firm investing in B2B software and tech-enabled services companies with $5-30M checks. Highly comparable to NMP in stage (revenue-stage growth), check size, and sector focus, though Frontier tends to be slightly larger in AUM.

TypeDirect peer
Description

Nashville-based growth equity firm exclusively focused on healthcare services and healthcare IT — directly overlapping NMP's largest vertical. Similar check sizes and growth-stage focus make it one of NMP's closest direct comparables in healthcare.

3Edison Partners
TypeDirect peer
Description

Princeton-based growth equity firm investing in technology-enabled financial and enterprise services. Comparable in stage ($5-25M checks, profitable growth companies), sector tilt, and 30+ year history as a focused growth investor.

TypeDirect peer
Description

Nashville-based growth equity firm focused exclusively on healthcare innovation and tech-enabled services. Direct overlap with NMP's healthcare IT thesis at similar check sizes and growth-stage profile.

TypeDirect peer
Description

Cleveland-based growth equity firm investing in technology and tech-enabled services. Notably, Vasant Kamath (now NMP GP) previously held senior roles at Primus, signaling deep sector overlap and team continuity between the firms.

TypeDirect peer
Description

Durham-based venture firm focused on healthcare IT and life sciences, often co-investing with NMP. Comparable in healthcare IT focus and growth-stage orientation, though Hatteras leans earlier-stage than NMP's typical entry.

TypeDirect peer
Description

Dallas-based growth equity firm investing in healthcare, business services, and tech-enabled companies. Similar check sizes, growth-stage focus, and sector tilt to NMP, with comparable fund structures.

TypeDirect peer
Description

San Diego-based growth equity firm focused exclusively on B2B software and SaaS companies. Directly comparable to NMP's B2B software thesis at similar revenue thresholds and growth profiles.

TypeDirect peer
Description

Boston-based growth equity firm investing in B2B software, healthcare IT, and tech-enabled services. Comparable stage focus ($5-25M checks), sector tilt, and growth-stage orientation to NMP.

TypeBroad incumbent
Description

New York-based scale-up investor with much larger fund size ($20B+ AUM) but overlapping healthcare IT and B2B software focus. Represents the competitive benchmark for exit multiples and the "graduation risk" as NMP portfolio companies scale beyond NMP's check size.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment154 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Noro-Moseley Partners

Venture Capital and Growth Equitynoromoseley.com

Noro-Moseley Partners is an Atlanta-based early growth equity firm founded in 1983 that invests $5-20M in B2B technology and healthcare companies with $2-20M in revenue and 50%+ growth, primarily across the Southeast and national US markets excluding the West Coast.

What Noro-Moseley Partners does

Noro-Moseley Partners (NMP) is an Atlanta-based early growth equity firm founded in 1983 that invests in B2B technology and healthcare companies across the United States (excluding the West Coast). The firm targets high-growth businesses with 50%+ year-over-year revenue growth, $2-20M revenue run rates, compelling unit economics, significant market disruption potential, and minimal prior funding (under $20M), deploying $5-20M per company. NMP's two sector pillars are software/SaaS/internet security/tech-enabled services (led by General Partner Alan Taetle) and healthcare IT and healthcare services (led by Managing General Partner Allen Moseley). The firm operates as a private limited partnership and has invested approximately $800M across 200+ companies since inception, with exits representing over $5B in aggregate enterprise value since 2015 and 13 exits since 2013 totaling $3.3B.

NMP earns revenue through a standard private equity structure: management fees (typically ~2%) on committed and invested capital across its fund vintages, and carried interest (typically ~20%) on profits from successful portfolio company exits. The firm closed its eighth fund (NMP VIII) in May 2019 at a hard cap of $180M, $30M oversubscribed against its $150M target. The LP base includes public and sovereign pension plans, health plans and health systems, foundations, endowments, and family offices, providing both capital and, in the healthcare segment, potential strategic partnership channels for portfolio companies. The investing team of approximately 10 professionals is led by four General Partners (Moseley, Taetle, Kamath, McClelland), supported by a Principal, Senior Associate, Vice President, and Executive-in-Residence.

Notable exits include Virtustream (acquired by Dell EMC for $1.2B in 2015), Wellcentive (acquired by Philips), Clearleap (IBM), FSLogix (Microsoft), Red Canary (Zscaler, 2025), TrendKite (Cision), Navitas Credit Corp, Contessa (Amedisys, 2021), SupplyPike (SPS Commerce, 2024), and Findhelp (TPG, 2026). The firm distributes its investment offering through direct relationships with founders and management teams, referrals from its portfolio ecosystem, and regional engagement via venture competitions such as Venture Atlanta. As a partnership, NMP is owned by its partners and is not publicly traded or affiliated with a parent entity.

Noro-Moseley Partners firmographics

Firmographics
Name
Noro-Moseley Partners
Legal name
Noro-Moseley Partners
Website
https://noromoseley.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
11–50 employees
Short description
Noro-Moseley Partners is an Atlanta-based early growth equity firm founded in 1983 that invests $5-20M in B2B technology and healthcare companies with $2-20M in revenue and 50%+ growth, primarily across the Southeast and national US markets excluding the West Coast.
Ownership category
akta.pro rank

Noro-Moseley Partners industry classification

Industry
Product category
Venture Capital and Growth Equity
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAO
Multi-Sector / Generalist Growth Equity

Keywords

  • Venture capital
  • Growth equity investing
  • Private equity
  • B2B technology investing
  • Healthcare venture capital

Where Noro-Moseley Partners is headquartered

Location

Headquarters

HQ city
Atlanta
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Noro-Moseley Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Management Fees: NMP charges management fees on their assets under management as a standard private equity practice. Fund VIII closed at $180 million with typical 2% management fee structure.
  2. Carried Interest: The firm earns carried interest (typically 20%) on profits from successful portfolio company exits. Their exits represent over $5 billion in aggregate enterprise value since 2015, generating substantial carried interest.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Noro-Moseley Partners product offering

Product offering

Core offering

Noro-Moseley Partners is a venture capital and early-growth equity firm that invests institutional fund capital into privately held B2B technology and healthcare companies, typically leading or co-leading expansion-stage rounds. The firm raises capital from limited partners into closed-end funds, deploys that capital into portfolio companies in exchange for equity, and provides board-level support, strategic guidance, and follow-on financing to founders and management teams.

Product overview

Noro-Moseley Partners is an early growth equity investment firm, not a technology product company. The firm provides investment capital and partnership services to B2B technology and healthcare companies. As such, it does not offer a unified product platform or individual software products/modules. Its investment offering consists of capital deployment ($5-20M investments), strategic advisory, and board-level support for portfolio companies.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Over $5 billion in aggregate enterprise value generated from exits since 2015
  • +3 more outcomes

Companies that use Noro-Moseley Partners

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Noro-Moseley Partners technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Noro-Moseley Partners partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Noro-Moseley Partners competitors and assessment

Company assessment

Direct peers

  • Frontier Capital: Charlotte-based growth equity firm investing in B2B software and tech-enabled services companies with $5-30M checks. Highly comparable to NMP in stage (revenue-stage growth), check size, and sector focus, though Frontier tends to be slightly larger in AUM.
  • Council Capital: Nashville-based growth equity firm exclusively focused on healthcare services and healthcare IT — directly overlapping NMP's largest vertical. Similar check sizes and growth-stage focus make it one of NMP's closest direct comparables in healthcare.
  • Edison Partners: Princeton-based growth equity firm investing in technology-enabled financial and enterprise services. Comparable in stage ($5-25M checks, profitable growth companies), sector tilt, and 30+ year history as a focused growth investor.
  • Heritage Group: Nashville-based growth equity firm focused exclusively on healthcare innovation and tech-enabled services. Direct overlap with NMP's healthcare IT thesis at similar check sizes and growth-stage profile.
  • Primus Capital: Cleveland-based growth equity firm investing in technology and tech-enabled services. Notably, Vasant Kamath (now NMP GP) previously held senior roles at Primus, signaling deep sector overlap and team continuity between the firms.
  • Hatteras Venture Partners: Durham-based venture firm focused on healthcare IT and life sciences, often co-investing with NMP. Comparable in healthcare IT focus and growth-stage orientation, though Hatteras leans earlier-stage than NMP's typical entry.
  • Trinity Hunt: Dallas-based growth equity firm investing in healthcare, business services, and tech-enabled companies. Similar check sizes, growth-stage focus, and sector tilt to NMP, with comparable fund structures.
  • TVC Capital: San Diego-based growth equity firm focused exclusively on B2B software and SaaS companies. Directly comparable to NMP's B2B software thesis at similar revenue thresholds and growth profiles.
  • Volition Capital: Boston-based growth equity firm investing in B2B software, healthcare IT, and tech-enabled services. Comparable stage focus ($5-25M checks), sector tilt, and growth-stage orientation to NMP.

Broad incumbents

  • Insight Partners: New York-based scale-up investor with much larger fund size ($20B+ AUM) but overlapping healthcare IT and B2B software focus. Represents the competitive benchmark for exit multiples and the "graduation risk" as NMP portfolio companies scale beyond NMP's check size.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

Noro-Moseley Partners social profiles

Digital presence

Noro-Moseley Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Noro-Moseley Partners leadership team

Management profile

Number of profiles

Noro-Moseley Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Noro-Moseley Partners M&A and investment

M&A and investment

M&A

Investments154 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noro-Moseley Partners

What does Noro-Moseley Partners do?

Noro-Moseley Partners is a venture capital and early-growth equity firm that invests institutional fund capital into privately held B2B technology and healthcare companies, typically leading or co-leading expansion-stage rounds. The firm raises capital from limited partners into closed-end funds, deploys that capital into portfolio companies in exchange for equity, and provides board-level support, strategic guidance, and follow-on financing to founders and management teams.

Is Noro-Moseley Partners a public or private company?

Noro-Moseley Partners is a private company. It is classified as management employee owned and is currently operating.

When was Noro-Moseley Partners founded?

Noro-Moseley Partners was founded in 1983. It employs 11 to 50 people.

Where is Noro-Moseley Partners based?

Noro-Moseley Partners is headquartered in Atlanta, United States, in the North America region.

How does Noro-Moseley Partners make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.

Who are Noro-Moseley Partners's main competitors?

Direct peers on record are Frontier Capital, Council Capital, Edison Partners, Heritage Group, Primus Capital, Hatteras Venture Partners, Trinity Hunt, TVC Capital and Volition Capital. Insight Partners is listed as a broad incumbent.

Does Noro-Moseley Partners have an API?

No public API is recorded for Noro-Moseley Partners.

What industry is Noro-Moseley Partners in?

Noro-Moseley Partners's product category is Venture Capital and Growth Equity. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Retail Technology Innovation HubEAIGLE bags funding from Noro-Moseley Partners for AI tech powered gate and yard automation push — Retail Technology Innovation HubEAIGLE, a Canadian AI-powered gate and yard automation startup, has secured an undisclosed funding round led by Noro-Moseley Partners, with participation from In Revenue Capital and Boreal Ventures. The funding will accelerate go-to-market expansion and further development of the company's Automated Vehicles Access Control (AVAC) and YardSight products, which use computer vision to automate real-time data capture at logistics facilities. Investors cited rapid adoption of the technology across retail, CPG, manufacturing, and transportation sectors as a key driver for the investment.AijournEAIGLE Secures Growth Funding from Noro-Moseley Partners and In Revenue Capital to Scale AI-Native Gate & Yard AutomationEAIGLE, an AI-native gate and yard automation company, announced it secured a growth funding round led by Noro-Moseley Partners with participation from In Revenue Capital and Boreal Ventures. The investment will accelerate go-to-market expansion and advance the company's computer vision platform for supply chain automation. The company reported over 350% year-over-year revenue growth with Fortune 500 customers and claims customers achieve ROI within 6 months with annual savings of $500,000.PR NewswireEAIGLE Secures Growth Funding from Noro-Moseley Partners and In Revenue Capital to Scale AI-Native Gate & Yard AutomationEAIGLE, an AI-native gate and yard automation company, has secured a growth funding round led by Noro-Moseley Partners with participation from In Revenue Capital and Boreal Ventures. The investment will accelerate go-to-market expansion and advance the company's computer vision platform for supply chain automation. Prior to this round, EAIGLE achieved over 350% year-over-year revenue growth with Fortune 500 customers, with its solutions reducing gate dwell time to under 30 seconds and delivering ROI within 6 months.ForbesEIAGLE Soars With Major New FundingEAIGLE, a U.S.-Canadian logistics technology company based in Boston and Toronto, has secured growth funding in a round led by Noro-Moseley Partners with participation from In Revenue Capital and Boreal Ventures, with the specific amount undisclosed. The company's AVAC and YardSight technologies automate commercial truck processing at freight yards, reducing gate check-in times to under 30 seconds and cutting theft and fraud by over 50%, with projected annual savings of $726,000 per facility. The new capital will fund national rollouts in the U.S. and Canada plus international expansion into Brazil, Mexico, India, and western Europe, including infrastructure for future autonomous truck fleets.FinSMEsEaigle Closes Growth FundingEaigle, a Boston-based AI-Native gate and yard automation company, raised an undisclosed amount in growth funding led by Noro-Moseley Partners with participation from In Revenue Capital and Boreal Ventures. The company will use the funds to accelerate go-to-market expansion and develop its proprietary automated logistics technology.//telecareaware.com/A study in contrasts: OpenAI raises $122B, eMed’s $200M Series A. Then there’s Avo’s $10M Series A, Stedi’s $50M Series C. And Oracle expands Nashville campus!OpenAI raised $122 billion, eMed raised $200 million in Series A, Avo raised $10 million, Stedi raised $50 million, and Oracle expanded its Nashville campus. The funding rounds span AI and healthcare, with Oracle leasing 116,000 square feet in Nashville.NoromoseleyNoro-Moseley PartnersNoro-Moseley Partners is investing in Revenue Analytics, a technology firm based in Atlanta, GA, that provides revenue management software and services for pricing optimization and demand forecasting. The initial investment was made in 2019 to leverage the company's operations research capabilities. This transaction represents a strategic financial commitment to the tech-enabled revenue optimization sector.Healthcare IT TodayKODE Raises $27M in Series B Funding to Transform Medical Coding and Data ManagementKODE Health raised $27 million in Series B funding led by Noro-Moseley Partners. The funding will expand its network of certified coders and develop AI-driven tools for healthcare providers. The company codes over a quarter million records monthly and has over 5,500 certified professionals.FinSMEsKode Raises $27M in Series B FundingKode Health raised $27M in Series B funding led by Noro-Moseley Partners. The company will use the funds to expand its network of certified coding professionals and develop AI-driven tools for hospitals. It has over 5,500 certified Koders who have coded over 8 million medical records.TmcnetKODE Raises $27M in Series B Funding to Transform Medical Coding and Data ManagementKODE Health raised $27 million in Series B funding led by Noro-Moseley Partners. The company, which codes over a quarter million medical records monthly, will use the funds to expand its network of certified coders and develop AI-driven tools for revenue cycle management.